Cutaneous T-cell lymphoma (CTCL) is a rare form of slow-growing cancer.It is caused by an abnormality in a certain type of white blood cell called a T lymphocyte, or T cell.
T cells are part of your immune system. Normally, they would help your body fight infections and regulate your immune response. But sometimes T cells can become cancerous, and some of them can collect in the skin. This collection of abnormal T cells in the skin is responsible for many of the symptoms of CTCL.
As the name suggests, CTCL is a type of cancer called a lymphoma, specifically a non-Hodgkin’s lymphoma, which differentiates it from another type of lymphoma known as Hodgkin’s lymphoma.3
Specially designed for medical professionals to use in their practice.
See top Opinion Leaders address FAQs about THERAKOS™ Photopheresis
Methoxsalen Sterile Solution is indicated for extracorporeal administration with the THERAKOS™ UVAR XTS® or THERAKOS™ CELLEX® Photopheresis System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.
Methoxsalen is not appropriate for patients who have had a reaction to psoralen compounds, patients who have had a light sensitive disease, or patients with an absence of one or both lenses of the eye.
THERAKOS™ Photopheresis is not appropriate for patients who cannot tolerate blood volume changes or patients with blood clotting disorders. See Important Safety Information for additional details.